Do analysts recommend MNTN or TRAK?

MNTN currently has a consensus target price of $19.85, suggesting a potential upside of 90.33%. Given MNTN's stronger consensus rating and higher possible upside, research analysts plainly believe MNTN is more favorable than ReposiTrak. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MNTN 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, MNTN or TRAK?

ReposiTrak has lower revenue, but higher earnings than MNTN. MNTN is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MNTN $290.09M 2.19 -$6.43M -$0.03 N/A ReposiTrak $22.61M 7.18 $6.98M $0.37 24.16

Is MNTN or TRAK more profitable?

ReposiTrak has a net margin of 30.75% compared to MNTN's net margin of 7.84%. MNTN's return on equity of 16.44% beat ReposiTrak's return on equity. Company Net Margins Return on Equity Return on Assets MNTN 7.84% 16.44% 13.03% ReposiTrak 30.75% 14.44% 12.85%

Does the media prefer MNTN or TRAK?

In the previous week, MNTN and MNTN both had 4 articles in the media. MNTN's average media sentiment score of 0.41 beat ReposiTrak's score of 0.18 indicating that MNTN is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MNTN 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ReposiTrak 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend TRAK or PHR?

Phreesia has a consensus price target of $16.65, indicating a potential upside of 50.58%. Given Phreesia's stronger consensus rating and higher possible upside, analysts clearly believe Phreesia is more favorable than ReposiTrak. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Phreesia 1 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.42

Which has stronger earnings & valuation, TRAK or PHR?

ReposiTrak has higher earnings, but lower revenue than Phreesia. ReposiTrak is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ReposiTrak $22.61M 7.18 $6.98M $0.37 24.16 Phreesia $480.59M 1.42 $2.31M $0.15 73.70

Is TRAK or PHR more profitable?

ReposiTrak has a net margin of 30.75% compared to Phreesia's net margin of 1.85%. ReposiTrak's return on equity of 14.44% beat Phreesia's return on equity. Company Net Margins Return on Equity Return on Assets ReposiTrak 30.75% 14.44% 12.85% Phreesia 1.85% 5.13% 3.12%

Does the media refer more to TRAK or PHR?

In the previous week, Phreesia had 21 more articles in the media than ReposiTrak. MarketBeat recorded 25 mentions for Phreesia and 4 mentions for ReposiTrak. ReposiTrak's average media sentiment score of 0.18 beat Phreesia's score of 0.14 indicating that ReposiTrak is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ReposiTrak 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Phreesia 3 Very Positive mention(s) 1 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend RMR or TRAK?

The RMR Group currently has a consensus target price of $19.00, indicating a potential downside of 7.05%. Given The RMR Group's stronger consensus rating and higher probable upside, equities analysts clearly believe The RMR Group is more favorable than ReposiTrak. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The RMR Group 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, RMR or TRAK?

The RMR Group has higher revenue and earnings than ReposiTrak. The RMR Group is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The RMR Group $700.28M 0.94 $17.60M $1.21 16.89 ReposiTrak $22.61M 7.18 $6.98M $0.37 24.16

Does the media refer more to RMR or TRAK?

In the previous week, The RMR Group had 1 more articles in the media than ReposiTrak. MarketBeat recorded 5 mentions for The RMR Group and 4 mentions for ReposiTrak. The RMR Group's average media sentiment score of 0.74 beat ReposiTrak's score of 0.18 indicating that The RMR Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The RMR Group 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ReposiTrak 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer TRAK or EVH?

Evolent Health has a consensus target price of $6.08, suggesting a potential upside of 2.41%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than ReposiTrak. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Evolent Health 1 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.65

Does the media favor TRAK or EVH?

In the previous week, ReposiTrak had 2 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for ReposiTrak and 2 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.58 beat ReposiTrak's score of 0.18 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ReposiTrak 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evolent Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate NVRI or TRAK?

Enviri presently has a consensus price target of $22.25, indicating a potential downside of 3.24%. Given Enviri's higher probable upside, equities analysts plainly believe Enviri is more favorable than ReposiTrak. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enviri 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, NVRI or TRAK?

ReposiTrak has lower revenue, but higher earnings than Enviri. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enviri $1.27B 0.51 -$167.60M N/A N/A ReposiTrak $22.61M 7.18 $6.98M $0.37 24.16

Is NVRI or TRAK more profitable?

ReposiTrak has a net margin of 30.75% compared to Enviri's net margin of -7.50%. ReposiTrak's return on equity of 14.44% beat Enviri's return on equity. Company Net Margins Return on Equity Return on Assets Enviri -7.50% -8.59% -1.09% ReposiTrak 30.75% 14.44% 12.85%

Does the media favor NVRI or TRAK?

In the previous week, ReposiTrak had 3 more articles in the media than Enviri. MarketBeat recorded 4 mentions for ReposiTrak and 1 mentions for Enviri. ReposiTrak's average media sentiment score of 0.18 beat Enviri's score of 0.00 indicating that ReposiTrak is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enviri 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ReposiTrak 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

ReposiTrak (TRAK) Competitors

$8.94 +0.03 (+0.34%)

As of 03:55 PM Eastern

Compare

TRAK vs. MNTN, PHR, RMR, EVH, and NVRI

Should you buy ReposiTrak stock or one of its competitors? MarketBeat compares ReposiTrak with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ReposiTrak include MNTN (MNTN), Phreesia (PHR), The RMR Group (RMR), Evolent Health (EVH), and Enviri (NVRI). These companies are all part of the "business services" industry.

How does ReposiTrak compare to MNTN?

MNTN (NYSE:MNTN) and ReposiTrak (NYSE:TRAK) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

MNTN currently has a consensus target price of $19.85, suggesting a potential upside of 90.33%. Given MNTN's stronger consensus rating and higher possible upside, research analysts plainly believe MNTN is more favorable than ReposiTrak.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MNTN	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

72.9% of MNTN shares are held by institutional investors. Comparatively, 27.4% of ReposiTrak shares are held by institutional investors. 19.6% of MNTN shares are held by insiders. Comparatively, 41.0% of ReposiTrak shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, MNTN and MNTN both had 4 articles in the media. MNTN's average media sentiment score of 0.41 beat ReposiTrak's score of 0.18 indicating that MNTN is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MNTN	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ReposiTrak	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MNTN has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, ReposiTrak has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

ReposiTrak has lower revenue, but higher earnings than MNTN. MNTN is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MNTN	$290.09M	2.19	-$6.43M	-$0.03	N/A
ReposiTrak	$22.61M	7.18	$6.98M	$0.37	24.16

ReposiTrak has a net margin of 30.75% compared to MNTN's net margin of 7.84%. MNTN's return on equity of 16.44% beat ReposiTrak's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MNTN	7.84%	16.44%	13.03%
ReposiTrak	30.75%	14.44%	12.85%

Summary

MNTN beats ReposiTrak on 9 of the 16 factors compared between the two stocks.

How does ReposiTrak compare to Phreesia?

ReposiTrak (NYSE:TRAK) and Phreesia (NYSE:PHR) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

ReposiTrak has a net margin of 30.75% compared to Phreesia's net margin of 1.85%. ReposiTrak's return on equity of 14.44% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ReposiTrak	30.75%	14.44%	12.85%
Phreesia	1.85%	5.13%	3.12%

Phreesia has a consensus price target of $16.65, indicating a potential upside of 50.58%. Given Phreesia's stronger consensus rating and higher possible upside, analysts clearly believe Phreesia is more favorable than ReposiTrak.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42

In the previous week, Phreesia had 21 more articles in the media than ReposiTrak. MarketBeat recorded 25 mentions for Phreesia and 4 mentions for ReposiTrak. ReposiTrak's average media sentiment score of 0.18 beat Phreesia's score of 0.14 indicating that ReposiTrak is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ReposiTrak	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phreesia	3 Very Positive mention(s)	1 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

27.4% of ReposiTrak shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 41.0% of ReposiTrak shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

ReposiTrak has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Phreesia has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

ReposiTrak has higher earnings, but lower revenue than Phreesia. ReposiTrak is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ReposiTrak	$22.61M	7.18	$6.98M	$0.37	24.16
Phreesia	$480.59M	1.42	$2.31M	$0.15	73.70

Summary

ReposiTrak and Phreesia tied by winning 8 of the 16 factors compared between the two stocks.

How does ReposiTrak compare to The RMR Group?

The RMR Group (NASDAQ:RMR) and ReposiTrak (NYSE:TRAK) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

ReposiTrak has a net margin of 30.75% compared to The RMR Group's net margin of 3.23%. ReposiTrak's return on equity of 14.44% beat The RMR Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The RMR Group	3.23%	3.44%	2.05%
ReposiTrak	30.75%	14.44%	12.85%

The RMR Group has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, ReposiTrak has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

In the previous week, The RMR Group had 1 more articles in the media than ReposiTrak. MarketBeat recorded 5 mentions for The RMR Group and 4 mentions for ReposiTrak. The RMR Group's average media sentiment score of 0.74 beat ReposiTrak's score of 0.18 indicating that The RMR Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The RMR Group	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ReposiTrak	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

The RMR Group has higher revenue and earnings than ReposiTrak. The RMR Group is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The RMR Group	$700.28M	0.94	$17.60M	$1.21	16.89
ReposiTrak	$22.61M	7.18	$6.98M	$0.37	24.16

42.3% of The RMR Group shares are owned by institutional investors. Comparatively, 27.4% of ReposiTrak shares are owned by institutional investors. 54.7% of The RMR Group shares are owned by company insiders. Comparatively, 41.0% of ReposiTrak shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

The RMR Group currently has a consensus target price of $19.00, indicating a potential downside of 7.05%. Given The RMR Group's stronger consensus rating and higher probable upside, equities analysts clearly believe The RMR Group is more favorable than ReposiTrak.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The RMR Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

The RMR Group pays an annual dividend of $1.80 per share and has a dividend yield of 8.8%. ReposiTrak pays an annual dividend of $0.08 per share and has a dividend yield of 0.9%. The RMR Group pays out 148.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ReposiTrak pays out 21.6% of its earnings in the form of a dividend. The RMR Group has raised its dividend for 1 consecutive years and ReposiTrak has raised its dividend for 2 consecutive years.

Summary

The RMR Group beats ReposiTrak on 12 of the 19 factors compared between the two stocks.

How does ReposiTrak compare to Evolent Health?

ReposiTrak (NYSE:TRAK) and Evolent Health (NYSE:EVH) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

In the previous week, ReposiTrak had 2 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for ReposiTrak and 2 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.58 beat ReposiTrak's score of 0.18 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ReposiTrak	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evolent Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Evolent Health has a consensus target price of $6.08, suggesting a potential upside of 2.41%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than ReposiTrak.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65

ReposiTrak has a net margin of 30.75% compared to Evolent Health's net margin of -26.29%. ReposiTrak's return on equity of 14.44% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ReposiTrak	30.75%	14.44%	12.85%
Evolent Health	-26.29%	0.36%	0.10%

ReposiTrak has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, Evolent Health has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

ReposiTrak has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ReposiTrak	$22.61M	7.18	$6.98M	$0.37	24.16
Evolent Health	$1.89B	0.35	-$534.51M	-$4.76	N/A

27.4% of ReposiTrak shares are held by institutional investors. 41.0% of ReposiTrak shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

ReposiTrak beats Evolent Health on 11 of the 16 factors compared between the two stocks.

How does ReposiTrak compare to Enviri?

Enviri (NYSE:NVRI) and ReposiTrak (NYSE:TRAK) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

93.4% of Enviri shares are owned by institutional investors. Comparatively, 27.4% of ReposiTrak shares are owned by institutional investors. 2.5% of Enviri shares are owned by company insiders. Comparatively, 41.0% of ReposiTrak shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ReposiTrak has a net margin of 30.75% compared to Enviri's net margin of -7.50%. ReposiTrak's return on equity of 14.44% beat Enviri's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enviri	-7.50%	-8.59%	-1.09%
ReposiTrak	30.75%	14.44%	12.85%

ReposiTrak has lower revenue, but higher earnings than Enviri.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enviri	$1.27B	0.51	-$167.60M	N/A	N/A
ReposiTrak	$22.61M	7.18	$6.98M	$0.37	24.16

Enviri has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market. Comparatively, ReposiTrak has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

In the previous week, ReposiTrak had 3 more articles in the media than Enviri. MarketBeat recorded 4 mentions for ReposiTrak and 1 mentions for Enviri. ReposiTrak's average media sentiment score of 0.18 beat Enviri's score of 0.00 indicating that ReposiTrak is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enviri	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ReposiTrak	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Enviri presently has a consensus price target of $22.25, indicating a potential downside of 3.24%. Given Enviri's higher probable upside, equities analysts plainly believe Enviri is more favorable than ReposiTrak.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enviri	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

ReposiTrak beats Enviri on 9 of the 14 factors compared between the two stocks.

Get ReposiTrak News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRAK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TRAK vs. The Competition

Export

Metric	ReposiTrak	INTERNET SOFTWARE Industry	Computer Sector	NYSE Exchange
Market Cap	$161.93M	$18.36B	$39.25B	$23.46B
Dividend Yield	0.90%	3.41%	3.19%	4.02%
P/E Ratio	24.16	68.46	170.02	31.08
Price / Sales	7.18	36.26	597.79	19.77
Price / Cash	19.64	77.06	45.82	18.64
Price / Book	3.30	6.76	9.49	4.77
Net Income	$6.98M	$385.08M	$1.07B	$1.06B
7 Day Performance	-5.89%	0.32%	-1.86%	-0.56%
1 Month Performance	-5.50%	6.53%	-1.40%	-0.11%
1 Year Performance	-53.12%	-7.95%	140.49%	16.64%

ReposiTrak Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TRAK ReposiTrak	0.5147 of 5 stars	$8.94 +0.3%	N/A	-53.0%	$161.93M	$22.61M	24.16	70
MNTN MNTN	4.4553 of 5 stars	$11.15 0.0%	$19.85 +78.1%	-54.7%	$680.14M	$290.09M	N/A	502	Analyst Downgrade
PHR Phreesia	4.0242 of 5 stars	$10.91 -0.3%	$16.65 +52.6%	-60.1%	$674.10M	$480.59M	72.71	1,789	Trending News
RMR The RMR Group	2.2192 of 5 stars	$20.50 flat	$19.00 -7.3%	+15.6%	$657.85M	$700.28M	16.94	600	Dividend Announcement
EVH Evolent Health	1.2779 of 5 stars	$5.70 -0.2%	$6.08 +6.7%	-47.5%	$640.91M	$1.88B	N/A	4,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TRAK) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ReposiTrak (TRAK) Competitors